mediate acting insulins and were studied twice with an interval of one week in between. Patients were randomised to receive either human Actrapid plus human Monotard or human Velosulin plus human Insulatard initially and then received the other combination during the second period of study. All insulins were of U40 strength. The tests began at least 30 minutes after cannulation. After an overnight fast the morning dose of short acting (mean 12-6 IU, range 4-36 IU) and intermediate acting insulin (mean 32-2 IU, range 16-52 IU) was administered by one of us. The insulins were injected perpendicularly into the thigh immediately after mixing in the syringe (Plastipak). The mean (range) ratio between short and intermediate acting insulin was 0-39 (0-11-0 90). After 30 minutes a standard liquid meal (2-1 MJ (500 kcal), 56u( carbohydrate) was taken. Blood glucose concentrations and plasma free insulin concentrations (measured by radioimmunoassay after plasma extraction with macrogol (polyethylene glycol)) were measured at regular intervals for four hours. Statistical analysis was by Student's paired t test and Kendall's rank correlation test. Results are given as means (1 SEM).
Postprandial blood glucose concentrations rose to higher peaks after short acting plus lente insulin than after short acting plus isophane insulin: from 9.9 (1-3) to 16-5 (1-5) mmol'l (178 (23 4) to 297 (27) mg/l00 ml) at 130 (9) minutes, compared with from 10-5 (1-2) to 13-6 (1-5) mmol/l (189 (21-6) to 245 (27) mg/1 00 ml) (p < 0-01) at 118 (6) minutes (figure). Blood Conversion: SI to traditional uinits-Glucose: 1 mmol/lz 18 mg/100 ml.
Plasma free insulin concentrations rose faster after short acting plus isophane insulin than after short acting plus lente insulin: from 20 (3) and 20 (3) mU/l to peaks of 91 (8) and 64 (7) mU/l (p< 001) at 137 (9) and 172 (13) minutes (p< 0-05), respectively. Plasma free insulin concentrations were significantly different from 30 to 165 minutes (figure). The initial rate of absorption of insulin (incremental peak concentration divided by the time in which it was reached) was significantly greater after short acting plus isophane insulin than after short acting plus lente insulin (0-54 (0-06) v 0-26 (0 04) mUjl/min (p< 0-001)). These values were positively correlated with the ratios of short to intermediate acting insulins (for short acting plus lente insulin r=0-62, p<0 01; for short acting plus isophane insulin r-=054, p< 02).
Comment
This study shows that mixing short acting with lente insulin in the syringe immediately before injection delays absorption of the insulin and causes higher postprandial blood glucose concentrations than a mixture of short acting plus isophane insulins. The results agree with our findings in healthy volunteers.2 Retarded absorption is probably caused by the excess of zinc in lente insulin, which binds the added short acting insulin.3-5 The relation between the rate of absorption of insulin and the ratio between short and intermediate acting insulins in the mixture suggests that the dosage of short acting insulin may be reduced by changing from a combination of a short acting plus lente insulin to a short acting plus isophane insulin.
Necrotising glomerulonephritis associated with cholesterol microemboli
Embolisation of cholesterol in the kidneys may result in severe, irreversible renal failure.' Antemortem diagnosis can sometimes be established by renal biopsy when characteristic crystalline clefts are seen in arterial lumens and ischaemic changes in the renal parenchyma.2 Although fibrinoid necrosis of small vessels has been associated with microemboli of cholesterol,3 necrotising angiitis in the kidney has not been reported as a manifestation of cholesterol embolisation. We describe a case of necrotising glomerulonephritis associated with cholesterol microemboli in an elderly man with extensive aortic atheromatosis.
Case report
A 75 year old man with chronic obstructive pulmonary disease was admitted to this hospital in October 1982 with acute bronchitis. He had a long history of coronary insufficiency and had recently experienced transient right hemianopsia. Results of biochemical tests were unremarkable apart from an increased erythrocyte sedimentation rate (72 mm in the first hour).
Serum urea concentration was 3-7 mmol/l (22 mg/l00 ml) and creatinine concentration 97 /umol/l (1 1 mg/100 ml); no proteinuria was found, and the urine sediment was normal. Treatment with antibiotics resulted in a rapid improvement of the pulmonary state. Funduscopic examination showed three cholesterol emboli in the right retina, and computed tomography of the brain indicated scattered bilateral ischaemic lesions. On 15 November carotid angiography was performed via the femoral artery. It showed an ulcerated atheromatous plaque in the right internal carotid artery and several stenotic lesions of the intracerebral vessels. Severe atheromatous lesions were present in the aorta.
On 21 December he developed oliguria and rapidly progressive renal failure. Blood urea nitrogen concentration was 32-5 mmol/l (91 mg/100 ml) and serum creatinine concentration was 407 Hmol/l (4-6 mg/100 ml). The urine sediment contained + + + red cells, and transient macroscopic haematuria was noted. Proteinuria was 1-5 g/day. On 23 December he was anuric and haemodialysis was started. Percutaneous renal biopsy two days later showed focal necrotising glomerulonephritis with the formation of crescents ( figure (A) ). Two small arterioles exhibited fibrinoid necrosis with the presence of needle shaped crystalline defts (figure (B) B: Arteriole with necrosis (arrow) around needle shaped crystalline deft. MAasson's trichrome X 300 (original magnification).
Comment
Our patient had evidence of atheroembolic disease in the retina, brain, and kidney. The necrotising glomerulonephritis was probably directly related to renal cholesterol embolisation because fibrinoid necrosis around a cholesterol crystal was observed in the renal biopsy specimen. Necrotising angiitis of distal vessels associated with cholesterol microemboli has been described in other organs,3 4 and cholesterol embolisation may result in a multisystemic disease simulating polyarteritis nodosa.3 Our case indicates that necrotising angiitis resulting from cholesterol embolisation may also occur in the kidney and lead to severe glomerulonephritis with formation of crescents similar to those observed in the microscopic form of polyarteritis nodosa.
Cholesterol embolisation may occur spontaneously but is usually a complication of angiographic procedures or aortic surgery.' In our case aortic catheterisation for carotid angiography may have had a role in the development of renal embolisation; the time between the angiography and the onset of renal failure was consistent with this hypothesis.' The nephropathy of our patient was rapidly progressive and irreversible, as usually occurs after renal cholesterol embolisation.5
Cholesterol embolisation may result in protean clinical manifestations and is recognised as a possible cause of renal failure in patients with aortic atheromatosis. ' We suggest that necrotising glomerulonephritis should be included in the clinical manifestationsof cholesterol eni.bolisation.
